NFKB1 and coronary artery disorder: Zhou et al discovered that the expression of miR‐30‐3p was increased significantly in the serum of patients with coronary heart disease, and that meanwhile, miR‐30‐3p inhibited the inflammatory responses and apoptosis induced by NF‐κB signals and MAPK pathway and further alleviated coronary artery injury.30